Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimized Treatment for HBV-induced Early Cirrhosis
NCT01938820Phase 4Completed
- Sponsor
- Beijing Friendship Hospital
- Start
- Jun 2013
- Primary completion
- Dec 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of thymosin alpha 1 in Liver cirrhosis (LC), sponsored by Beijing Friendship Hospital. Started Jun 2013; status: completed.
02
Drugs
thymosin alpha 1
03
Conditions
Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT01938820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01938820.